DARANIDE

Serial Number 85366296
606

Registration Progress

Application Filed
Jul 8, 2011
Under Examination
Jun 12, 2012
Approved for Publication
Apr 17, 2012
Published for Opposition
Apr 17, 2012
Registered

Basic Information

Serial Number
85366296
Filing Date
July 8, 2011
Published for Opposition
April 17, 2012
Abandonment Date
July 13, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 13, 2015
Classes
005

Rights Holder

Taro Pharmaceuticals U.S.A., Inc.

03
Address
3 Skyline Drive
Hawthorne, NY 10532

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Taro Pharmaceuticals U.S.A., Inc.

Original Applicant
03
Hawthorne, NY

Taro Pharmaceuticals U.S.A., Inc.

Owner at Publication
03
Hawthorne, NY

Legal Representation

Attorney
Marcia A. Auberger

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

40 events
Date Code Type Description
Jul 13, 2015 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Jul 13, 2015 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 16, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 15, 2014 EX5G S SOU EXTENSION 5 GRANTED
Dec 9, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 9, 2014 EXT5 S SOU EXTENSION 5 FILED
May 13, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2014 EX4G S SOU EXTENSION 4 GRANTED
May 8, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
May 8, 2014 EXT4 S SOU EXTENSION 4 FILED
Nov 13, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2013 EX3G S SOU EXTENSION 3 GRANTED
Nov 5, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 5, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 5, 2013 EXT3 S SOU EXTENSION 3 FILED
May 17, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2013 EX2G S SOU EXTENSION 2 GRANTED
May 10, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 18, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 18, 2013 EXT2 S SOU EXTENSION 2 FILED
Oct 30, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 26, 2012 EXT1 S SOU EXTENSION 1 FILED
Oct 26, 2012 EX1G S SOU EXTENSION 1 GRANTED
Jun 12, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 17, 2012 PUBO A PUBLISHED FOR OPPOSITION
Apr 17, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 5, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 1, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2012 ACEC I AMENDMENT FROM APPLICANT ENTERED
Feb 17, 2012 ALIE A ASSIGNED TO LIE
Feb 8, 2012 MAIL I PAPER RECEIVED
Sep 9, 2011 CNRT R NON-FINAL ACTION WRITTEN
Sep 9, 2011 GNRT F NON-FINAL ACTION E-MAILED
Sep 9, 2011 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2011 DOCK D ASSIGNED TO EXAMINER
Jul 13, 2011 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2011 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Medicinal Preparation for Use in the Treatment of Glaucoma, of Respiratory Acidosis Accompanying Pulmonary Insufficiency and as a Diuretic
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005